Cipla Ltd. — Interim / Quarterly Report 2019

Jun 24, 2019

21st June, 2019

• (1) BSE Ltd Listing Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
• (2) National Stock Exchange of India Ltd Listing Department Exchange Plaza, 5th floor, Plot no. C/1, G Block, Sandra Kurla Complex, Sandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA EQ

(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Disclosure of related party transactions for the half year ended 31 51March, 2019

Dear Sir/Madam,

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 31st March, 2019.

This disclosure is also being uploaded on the website of the Company i.e. www.cipla.com.

This is for your information and record.

Thanking you,

Yours faithfully, For Cipla Limited

Rajendra Chopra Company Secretary

Prepared by: Vivek Vadwana

Information on related party transactions as required by lnd AS-24 - 'Related Party Disclosures' are given below:

List of related parties

A. Associate

Stempeutics Research Private Limited Avenue Therapeutics Inc. (w.e.f. 8th February, 2019)

B. Key Management Personnel

Ms. Samina Vaziralli- Executive Vice-Chairperson Mr. Umang Vohra- Managing Director and Global Chief Executive Officer Mr. S. Radhakrishnan- Whole-time Director (upto 11th November, 2017) Mr. Kedar Updhaye- Global Chief Financial Officer Dr. Raghunathan Ananthanarayanan - President and Global Chief Operating Officer (w.e.f. ogth August, 2018)

C. Non-Executive Chairman & Non-Executive Vice Chairman

Dr. Y. K. Hamied, Chairman Mr. M. K. Hamied, Vice Chairman

D. Non-Executive Directors

• Mr. Ashok Sinha Mr. Adil Zainulbhai Ms. Punita Lal Ms. Naina Lal Kidwai Ms. lreena Vittal (Upto 31st March, 2019) Mr. Peter Lankau Dr. Peter Mugyenyi Mr. S Radhakrishnan (w.e.f 12th November, 2017)
• E. Entities over which Key Management Personnel are able to exercise significant influence

Cipla Foundation Hamied Foundation Cipla Cancer and AIDS Foundation

F. Trust over which entity has control/significant influence

Cipla Limited Employees Provident Fund Cipla Limited Employees Gratuity Cipla Employees Stock Option Trust Cipla Health Employees Stock Option Trust

		Rs. in Crore
Particulars		For the half year ended31st March, 2019
A.	Remuneration (Including sitting fees)*
	Dr. Y.K. Hamied	1.02
	Mr. M.K. Hamied	1.03
	Ms. Samina Vaziralli	3.50
	Mr. Umang Vohra	8.54
	Mr. S. Radhakrishnan	1.04
	Mr. Kedar Upadhye	1.79
	Mr. Ashok Sinha	0.23
	Mr. Adil Zainulbhai	0.19
	Ms. Punita lal	0.20
	Ms. Naina lal Kidwai	0.21
	Ms. lreena Vittal	0.20
	Mr. Peter lankau	0.22
	Dr. Peter Mugyenyi	0.22
	Dr. Raghunathan Ananthanarayanan	3.87
		22.26

* Expenses towards gratuity and leave encashment provisions are determined actuarially on an overall company basis at the end of each year and accordingly have not been considered in the above information

B.	Purchase of goods
	Stempeutics Research Private limited	0.16
		0.16
c.	Testing and analysis charges paid
	Stempeutics Research Private limited	1.59
		1.59
D.	Contribution to provident fund and other fund
	Cipla limited Employees Gratuity Fund	15.00
	Cipla limited Employees Provident Fund	20.84
		35.84
E.	Donations given
	Cipla Foundation	18.80
		18.80
F.	Rent received
	Dr. Y.K. Hamied (Rs.10,020/-)	0.00
		0.00
G.	Reimbursement of operating/other expenses
	Stempeutics Research Private limited	0.18
		0.18
	Cipla Ltd. Regd. Office Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai
	Phone +91 22 24826000 Fax +91 22 24826120 E-mail contactus@cipla.com Website www.cipla.com

Corporate Identity Number L24239MH1935PLC002380

For the half year endedParticulars31st March, 2019Investment made during the periodH.Avenue Therapeutics Inc.242.04242.04Payable to Key Management PersonnelI.Dr. Y.K. Hamied2.002.00Mr. M.K. HamiedMs. Samina Vaziralli2.30Mr. Umang Vohra5.50Mr. S.Radhakrishnan2.00Mr. Kedar Upadhye0.91Mr. Ashok Sinha0.400.32Mr. Adil Zainulbhai0.35Ms. Punita Lal0.35Ms. Naina Lal KidwaiMs. lreena Vittal0.35Mr. Peter Lankau0.40Dr. Peter Mugyenyi0.40Dr. Raghunathan Ananthanarayanan1.7819.06Contribution payable to provident fundJ.
Cipla Employees Provident Fund3.40
3.40
Advances receivable from gratuity fundK.
Cipla Limited Employees Gratuity Fund9.51
9.51